Evidence map›Paper›PMID 35046895›Full record

ArticleFrontiers in endocrinology2021

qPCR Analysis Reveals Association of Differential Expression of

Waseem Raza, Jinlei Guo, Muhammad Imran Qadir, Baogang Bai, Syed Aun Muhammad

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Waseem RazaInstitute of Molecular Biology and Biotechnology, Bahauddin Zakariya University, Multan, Pakistan.
Jinlei GuoSchool of Medical Engineering, Sanquan College of Xinxiang Medical University, Xinxiang, China.
Muhammad Imran QadirInstitute of Molecular Biology and Biotechnology, Bahauddin Zakariya University, Multan, Pakistan.
Baogang BaiSchool of Information and Technology, Wenzhou Business College, Wenzhou, China.
Syed Aun MuhammadInstitute of Molecular Biology and Biotechnology, Bahauddin Zakariya University, Multan, Pakistan.
Bahauddin Zakariya University · PKWenzhou University · CNXinxiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Type 2 diabetes mellitus (T2DM) is a heterogeneous, metabolic, and chronic condition affecting vast numbers of the world's population. The related variables and T2DM associations have not been fully understood due to their diverse nature. However, functional genomics can facilitate understanding of the disease. This information will be useful in drug design, advanced diagnostic, and prognostic markers. Aim: To understand the genetic causes of T2DM, this study was designed to identify the differentially expressed genes (DEGs) of the disease. Methods: We investigated 20 publicly available disease-specific cDNA datasets from Gene Expression Omnibus (GEO) containing several attributes including gene symbols and clone identifiers, GenBank accession numbers, and phenotypic feature coordinates. We analyzed an integrated system-level framework involving Gene Ontology (GO), protein motifs and co-expression analysis, pathway enrichment, and transcriptional factors to reveal the biological information of genes. A co-expression network was studied to highlight the genes that showed a coordinated expression pattern across a group of samples. The DEGs were validated by quantitative PCR (qPCR) to analyze the expression levels of case and control samples (50 each) using glyceraldehyde 3-phosphate dehydrogenase ( Results: From the list of 50 DEGs, we ranked three T2DM-related genes ( Conclusion: This study would help to modulate the therapeutic strategies for T2DM and could speed up drug discovery outcomes.

Indexed as

Cyclic Nucleotide Phosphodiesterases, Type 4Diabetes Mellitus, Type 2Gene ExpressionHumansNF-KappaB Inhibitor alphaRacemases and EpimerasesReal-Time Polymerase Chain ReactionSerine RacemaseCyclic Nucleotide Phosphodiesterases, Type 4NF-KappaB Inhibitor alphaNFKBIA protein, humanPDE4B protein, humanRacemases and EpimerasesSerine RacemasecDNA datasetsdifferential expressed genesenrichment analysisexpression profilingqPCRT2DM

Identifiers

PMID35046895
PMCPMC8761634
OpenAlexW4205108148

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.